<qa>  What is the purpose of this study?The purpose of this study is to compare the efficacy and safety of Endostar Recombinant Human Endostatin combined with Docetaxel and single Docetaxel through multi-center, double-blinding, randomized controlled, phase IV clinical trial for NSCLC cases who have obvious progressive disease or intolerant adverse effects in first-line chemotherapy. 